EP Biocomposites Share Price

EP Biocomposites Limited is a small‑cap company operating in the plastic products industry, engaged in the manufacture and sale of fibre‑reinforced polymer (FRP) products. Headquartered in Ahmedabad, Gujarat, the company was incorporated in 1991 and manufactures FRP doors, panels, bio‑digester toilets, sewage treatment plants, and effluent treatment plants. The EP Biocomposites share price on the NSE and BSE is a reflection of how market participants respond to a performance and broader business developments within its industry. It captures the company’s sentiment of the investors based on financial results, operational updates, macroeconomic factors, and trends specific to sectors. Movements in the share price͏ reveal how the market evaluates the company’s current position and its future prospects, making ͏it a key indicator of market perception across various industries. 

Market sentiment around the EP Biocomposites stock price often mirrors shifts in government schemes for sanitation, industrial demand for FRP products, and investor views on the prospects for small‑cap manufacturing firms. Factors such as the company’s ability to secure new contracts, manage raw material costs, and government policies on wastewater treatment influence near‑term valuation and medium‑term earnings forecasts. All these factors must be closely monitored to have an idea about the EP Biocomposites share price movements. 

The EP Biocomposites live share price provides real‑time information about the last price traded, bid price, ask price, and volume traded. These indicators represent trading activity and liquidity and the reaction of investors to corporate announcements, quarterly results, and sector news. Constant monitoring of EP Biocomposites live price helps observe short‑term price fluctuations and understand how the stock is moving in relation to the broader market. 

Furthermore, monitoring the EP Biocomposites share price today helps investors understand real‑time market sentiment, price volatility, and trading behaviour. It allows market participants to evaluate short‑term performance, identify possible entry or exit points, and respond to news, quarterly results or sector trends that may affect the company’s valuation and overall investment outlook. The EP Biocomposites stock price remains sensitive to the capital goods sector. EP Biocomposites share price movements are closely tied to the FRP products and sanitation infrastructure segments. 

EP Biocomposites Limited Company Fundamentals 

A. Company Background

EP Biocomposites Limited was incorporated in 1991. The company’s registered office is located in Ahmedabad, Gujarat, India. EP Biocomposites Limited manufactures and sells fibre‑reinforced polymer (FRP) products in India. The company offers bio‑digester toilets, sewage and effluent treatment plants, FRP doors, FRP panels, and various FRP products for industrial and residential applications. As a small‑cap entity, it operates in a competitive environment within the plastic and FRP products industry. The company is listed on the Bombay Stock Exchange (BSE) under the scrip code 543595. The company has 55 employees as per its latest filings. EP Biocomposites operates in the Plastic Products sector and is classified as a Small Cap company by SEBI. The company’s revenue had been growing strongly in earlier years, but recent quarters have seen a sharp decline in revenue from operations. 

B. Product Lines 

• Bio‑digester toilets for sanitation infrastructure 

• Sewage treatment plants (STP) for wastewater management 

• Effluent treatment plants (ETP) for industrial wastewater 

• Fibre‑reinforced polymer (FRP) doors for residential and industrial use 

• FRP panels for construction and industrial applications 

• Fibre‑reinforced polymer (FRP) moulded products 

• GRP (Glass‑Reinforced Plastic) products 

C. Company Revenue Model 

• Primary revenue from manufacture and sale of FRP products including bio‑digester toilets, sewage treatment plants, and FRP doors. 

• Project‑based revenue from government sanitation contracts and industrial wastewater treatment projects. 

• Volume‑driven revenue based on quantity of FRP products manufactured and sold. 

• Pricing determined by raw material costs (fibreglass, resins) and market demand. 

• Revenue from the domestic Indian market, with no significant international operations reported. 

• Focus on expanding product portfolio in the water treatment and sanitation infrastructure sectors. 

• Seasonal variations in government contract awards affecting revenue patterns. 

• Government policy changes on sanitation infrastructure funding influencing revenue stability. 

D. Geographic Presence 

• Headquartered in Ahmedabad, Gujarat, India. 

• Operations focused on the domestic FRP products and sanitation infrastructure market. 

• No significant international presence reported. 

• Serves customers across multiple states within India through project‑based contracts. 

E. Key Milestones 

• 1991 – Company incorporated. 

• 2021 – Listed on the Bombay Stock Exchange (BSE). 

• Identified as a key player in fibre‑reinforced polymer (FRP) products for infrastructure projects. 

• Revenue CAGR of 83.96% over five years before recent slowdown. 

F. Industry Perspective

EP Biocomposites operates in the plastic products manufacturing industry, specifically in the FRP (fibre‑reinforced plastic) and water treatment equipment segment. The global FRP market is projected to grow at a CAGR of approximately 5‑6% through 2030, reaching around USD 150 billion. However, the Indian FRP market is growing faster, at an estimated CAGR of 10‑12%, driven by increasing industrial demand, infrastructure spending, and adoption of corrosion‑resistant materials in construction and wastewater treatment. The market for bio‑digester toilets has seen a surge due to the Swachh Bharat Mission, with the government supporting the installation of millions of such units in rural and semi‑urban areas. The sewage and effluent treatment plant market in India is expanding at a CAGR of 7‑9%, fuelled by stricter pollution control norms from the Central Pollution Control Board (CPCB) and the government’s push for water recycling. Key drivers include government spending on the Namami Gange project, the Jal Jeevan Mission, and the creation of new industrial estates with mandatory effluent treatment facilities. Challenges for the industry include volatile raw material prices (fibreglass, resins which are petrochemical derivatives), intense competition from unorganised local manufacturers, project execution risks (including delays in government payments), and high working capital requirements due to the project‑based nature of the business. The increase in US tariffs on Indian processed products and pressure on export demand for other manufacturing industries have also impacted the overall industrial climate for small‑scale FRP manufacturers, causing some project deferrals. In recent quarters, EP Biocomposites has reported a significant fall in revenue, from ₹760.13 lakhs in the same period last year to ₹407.48 lakhs in the latest quarter, reflecting the challenging execution environment. 

EP Biocomposites Limited Stock Market Presence: Listings & Index Representation 

EP Biocomposites is actively traded on the Bombay Stock Exchange (BSE) under the scrip code 543595. The company is not listed on the National Stock Exchange (NSE), but it is listed on the BSE SmallCap platform. The ISIN for the company is INE0D2I01014. Its listing on the BSE ensures that the EP Biocomposites share price is accessible to a wide investor base, encompassing both retail and institutional market participants. The company forms part of several benchmark indices on the BSE. EP Biocomposites is included in the BSE SmallCap index and the BSE AllCap index. On the NSE, the company does not currently have a listing, and therefore, it is not a constituent of any Nifty indices. Being represented in these small‑cap indices enhances the visibility and liquidity of the EP Biocomposites stock price, as index tracking funds may adjust allocations in line with constituent revisions. However, the company’s absence from the NSE and major indices limits its visibility to institutional investors to some extent. The inclusion of EP Biocomposites in the BSE SmallCap index reflects its status as a small‑cap company operating in the plastic products sector. 

EP Biocomposites Limited Stock Performance and Share Price History 

The performance and share price history of EP Biocomposites Limited are influenced by a complex mix of operational challenges, government contract awards, and sectoral factors. A primary driver is the company’s ability to secure and execute government contracts for bio‑digester toilets and sewage treatment plants, as any slowdown in project execution directly impacts the EP Biocomposites share price. Government policies regarding the Swachh Bharat Mission, sanitation infrastructure budgets, and pollution control norms also play a critical role. For instance, when government spending on sanitation is increased, the EP Biocomposites share price often sees a positive reaction. Conversely, delays in government payments or project deferrals put pressure on the EP Biocomposites stock price. 

Another major factor is competition from both organised FRP product manufacturers and unorganised local players, which can alter long‑term growth projections and influence the EP Biocomposites share price. The company’s revenue growth directly impacts investor sentiment. Quarterly financial results, especially net profit and sales volume figures, cause immediate swings in the EP Biocomposites stock price. Additionally, broader market trends and even seasonal government budget cycles contribute to volatility. Historically, the EP Biocomposites share price has shown sharp declines during phases of weak revenue growth and raw material cost inflation. 

The 52‑week high of the stock is largely dictated by sentiment shifts and external shocks. When the company reports robust revenue growth from its bio‑digester toilet business, the EP Biocomposites share price tends to rally toward its 52‑week high; conversely, a sharp drop in revenue can drive the EP Biocomposites share price down to a new low. The EP Biocomposites share price also hits its peak when management announces new government contracts, while a sharp rise in raw material costs pushes the EP Biocomposites share price toward the yearly bottom. Broader market sell‑offs, such as during economic uncertainty, often drag the EP Biocomposites share price to multi‑month lows, even if fundamentals are stable. Conversely, a bullish narrative on water treatment infrastructure spending can lift the EP Biocomposites share price to a new 52‑week high. Additionally, quarterly earnings misses have historically pressured the EP Biocomposites share price to test its lowest levels. 

The EP Biocomposites share price has exhibited significant volatility over the past few years, especially since its listing in 2021. The EP Biocomposites share price delivered a strong rally in its initial listing period, but the subsequent period has seen the EP Biocomposites share price correct sharply from its peak levels. The EP Biocomposites share price reached a 52‑week high of 149.90 and a 52‑week low of 75.50, indicating a wide trading range. The EP Biocomposites share price has shown a 1‑year return of -26.7% to -29.8% and a 3‑year return of -24.5% to -52.21%, significantly underperforming broader market indices and reflecting near‑term headwinds including revenue declines and project delays. The EP Biocomposites share price recorded a strong rally in 2022‑2023, while the subsequent period has seen the EP Biocomposites share price moderate and correct from its peak levels. The EP Biocomposites share price has shown a 1‑month return of approximately -6.12% and a 6‑month return that has also been negative. 

The EP Biocomposites stock price has been particularly responsive to quarterly earnings releases. When the company reported a 89% decline in revenue from operations, from ₹760.13 lakhs to ₹407.48 lakhs, the EP Biocomposites stock price showed a strong negative reaction. The EP Biocomposites stock price has shown a pattern of volatility in years when the company’s earnings were inconsistent. The EP Biocomposites stock price has shown a market capitalisation that has fluctuated from ₹282.91 million at listing down to ₹145‑169 million as of recent quarters. 

The EP Biocomposites share price reached its 52‑week high before declining, reflecting the volatility inherent in the FRP manufacturing space. The EP Biocomposites share price has shown a year‑to‑date return that has been negative as of 2026. Comprehending these patterns in the EP Biocomposites share price is instrumental, as the EP Biocomposites stock price movements illustrate how capital‑goods sector fundamentals and investor expectations converge in market pricing. 

The EP Biocomposites share price has shown distinct seasonal patterns. In terms of annual performance, the EP Biocomposites share price delivered a 47.0% decline in 2025 and 8.5% decline in 2024. The stock recorded its strongest returns in the period immediately following its listing in 2021‑2022. The EP Biocomposites share price has demonstrated that the stock tends to perform better in periods of high government spending on sanitation and water treatment projects and stable raw material resin prices. 

EP Biocomposites Limited Investor Relevance and Role in Portfolio 

EP Biocomposites holds a niche position for portfolio investors who seek exposure to the FRP products and water treatment sector. The company’s operations in bio‑digester toilets and sewage treatment plants align it with investment strategies that value infrastructure and government contract opportunities. The EP Biocomposites share price often mirrors how these themes resonate with investor portfolios, whereby both thematic and sector‑specific funds might monitor government budget allocations for sanitation when evaluating allocation decisions. 

Institutional stakeholders play a significant role in EP Biocomposites’ ownership profile. Promoters hold approximately 70.08% of the company’s total shares as of recent quarters, and none of the promoter shares are pledged. Mutual funds do not hold any stake. Foreign Institutional Investors (FII) and Domestic Institutional Investors (DII) currently hold 0% as per latest reports. Retail public holds approximately 17.12‑17.4% after adjusting for promoters. The high promoter holding of over 70% indicates strong promoter confidence, but the complete absence of institutional investors suggests limited institutional interest in this micro‑cap name. 

Based on data, EP Biocomposites exhibits varying levels of beta and volatility across different time horizons. Based on data, the long‑term beta of EP Biocomposites stands at -0.49 to 1.53 depending on the source, indicating a mixed correlation with the broader market. Based on data, the weekly volatility stands at approximately 8‑10%, which has been stable over the past year but is still higher than 75% of Indian stocks. Based on data, the beta coefficient from different sources varies significantly. Based on data, the mean values for long‑term range is 86.00, daily‑one month range is 86.00, daily‑three month range is 86.00, weekly‑one year range is 86.00, weekly‑two year range is 86.00, 2 week‑two year range is 86.00, monthly‑two year range is 86.00. Standard deviations range from 0.10 to 5.00 across periods. Overall, EP Biocomposites demonstrates a high volatility profile, making it sensitive to broader market shifts and company‑specific news. The EP Biocomposites stock price has shown periods of heightened responsiveness to sector‑specific news regarding government contracts for sanitation infrastructure. The EP Biocomposites share price’s beta reflects that the company’s small size makes it subject to company‑specific factors rather than broad market trends. The EP Biocomposites share price has historically moved on earnings announcements and government budget allocations. 

EP Biocomposites Limited Sectoral Relevance and Peer Positioning 

The sector relevance of EP Biocomposites is anchored in its role within the broader Indian plastic products industry, specifically the FRP and water treatment segment. Competitors in the plastic products and water treatment segment include companies such as Garware Technical Fibres Ltd, Visaka Industries Ltd, Oriental Pipes Ltd, Prince Pipes and Fittings Ltd, and Supreme Industries Ltd. Firms with parallels in operational scale are often referenced when evaluating relative performance. However, EP Biocomposites remains a very small player compared to the industry leaders. 

In valuation terms, factors like the EP Biocomposites P/E ratio have shown variations over different periods. The mean historical PE Ratio over the last few years has been volatile. The current P/E ratio stands at approximately 14.13 to 18.53 times, trading at a 18% discount to the peer median range of 17.23 times. The P/E ratio for EP Biocomposites was elevated in the post‑listing period. In 2025-2026, the P/E ratio has moderated, reflecting lower earnings expectations. The price‑to‑book (P/B) ratio is 1.40‑1.59. The company has delivered a revenue CAGR of 83.96% over five years before the recent slowdown, but net profit growth has been inconsistent. 

Similarly, the EP Biocomposites EPS narrative has shown variation according to how operational performance aligns with industry cycles. The TTM EPS stands at approximately ₹6.13 from continuing operations. The company generated earnings of ₹6.79 per share in FY24 but saw a decline to ₹6.12 in FY25, representing a 10% annual drop. EP Biocomposites earnings have shown a trajectory of strong growth from FY21 to FY24 (from 3.68 to 6.79) but then a decline in the most recent period. The decline is due to falling revenue from operations and rising operating expenses. Annual revenue grew from 71.31 crore in FY23 to 114.39 crore in FY24 (a 60% surge), but then only 2.4% to 120.06 crore in FY25. For the latest quarter (Dec 2025), revenue dropped 89% to ₹407.48 lakhs. 

EP Biocomposites market cap has fluctuated between approximately ₹17 crore and ₹28 crore over the past few years. From its listing in September 2021, the market cap expanded to ₹28 crore (₹282.91 million) but has since fallen to ₹14.5‑17 crore, a decrease of 39.97% at a CAGR of -13.17%. This decrease mirrors the correction in the EP Biocomposites share price following revenue declines. 

The EP Biocomposites earnings over the past few years have been characterised by strong growth followed by recent moderation. Net income rose from ₹3.43 crore in FY23 to ₹6.79 crore in FY24, but then dipped to ₹6.12 crore in FY25. The EP Biocomposites share price has been influenced by these valuation metrics. The EP Biocomposites stock price continues to be evaluated in the context of its ability to win new government contracts and restore revenue growth. The company’s strong promoter holding of 70% provides some stability, but the 89% quarterly revenue decline is a significant concern. 

Summary 

EP Biocomposites is a micro‑cap FRP products company listed on the BSE, where the EP Biocomposites share price reflects sanitation infrastructure spending, raw material price fluctuations, and small‑cap manufacturing sentiment. Its inclusion in the BSE SmallCap index supports limited visibility, while investor interest is shaped by earnings trends and broader water treatment infrastructure demand themes. Within the sector, the company’s competitive context and earnings dynamics provide limited perspective on its role in the FRP products industry.